Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia

被引：30

作者：

Meggendorfer, Manja ^{[1
]}

de Albuquerque, Andreia ^{[1
]}

Nadarajah, Niroshan ^{[1
]}

Alpermann, Tamara ^{[1
]}

Kern, Wolfgang ^{[1
]}

Steuer, Kimberly ^{[1
]}

Perglerova, Karolna ^{[2
]}

Haferlach, Claudia ^{[1
]}

Schnittger, Susanne ^{[1
]}

Haferlach, Torsten ^{[1
]}

机构：

[1] MLL Munich Leukemia Lab, Munich, Germany

[2] MLL2 Sro, Prague, Czech Republic

来源：

HAEMATOLOGICA | 2015年 / 100卷 / 12期

关键词：

MDS; s-AML; mutation analysis; MUTATIONS; FREQUENCY; PROGNOSIS; NPM1; NRAS; MDS;

D O I：

10.3324/haematol.2015.127985

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E487 / E490

页数：4

共 50 条

[11] FLT3 Inhibitors in Acute Myeloid Leukemia
Stone, Richard M.
ONCOLOGIST, 2016, 21 : S2 - S2
[12] FLT3 inhibitors in acute myeloid leukemia
Mei Wu
Chuntuan Li
Xiongpeng Zhu
Journal of Hematology & Oncology, 11
[13] FLT3 inhibitors in acute myeloid leukemia
不详
ANNALS OF HEMATOLOGY, 2008, 87 : S87 - S89
[14] FLT3 Inhibitors for Acute Myeloid Leukemia
Lancet, Jeffrey E.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 573 - 575
[15] FLT3 inhibitors in acute myeloid leukemia
Pastore, Domenico
DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2016, 4 (01): : 14 - 21
[16] FLT3 inhibitors in acute myeloid leukemia
el-Shami, Khaled
Stone, Richard M.
Smith, B. Douglas
EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (02) : 153 - 160
[17] PROGNOSTIC SIGNIFICANCE OF FLT3 MUTATIONS IN NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA PATIENTS IN INDIA
Kumar, B.
Hasan, K. Syed
Sharma, V.
Asthana, B.
Kumar, R.
Anand, H.
Mahapatra, M.
Saxena, R.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 545 - 545
[18] Acute Myeloid Leukemia Associated With Near-Tetraploid Karyotype and Mutations in the FLT3 Gene
Jurisic, Vladimir
Pavlovic, Sonja
Colovic, Natasa
Djordjevic, Vesna
Jankovic, Gradimir
Colovic, Milica
LABMEDICINE, 2011, 42 (09): : 540 - 543
[19] Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations
Matsumoto, Yosuke
Kato, Daishi
Muramatsu, Ayako
Sugitani, Mio
Kobayashi, Tsutomu
Iwai, Toshiki
Mori, Minako
Motooka, Daisuke
Nakata, Jun
Ogawa, Seishi
Nannya, Yasuhito
Uchiyama, Hitoji
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025,
[20] FLT3 Inhibitors for Treating Acute Myeloid Leukemia
Hassanein, Mona
Almahayni, Muhamad H.
Ahmed, Syed O.
Gaballa, Sameh
El Fakih, Riad
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (10): : 543 - 549

← 1 2 3 4 5 →